标题
Trial Watch
作者
关键词
-
出版物
OncoImmunology
Volume 2, Issue 8, Pages e25238
出版商
Informa UK Limited
发表日期
2013-09-18
DOI
10.4161/onci.25238
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Heat Shock Protein 70, Released from Heat-Stressed Tumor Cells, Initiates Antitumor Immunity by Inducing Tumor Cell Chemokine Production and Activating Dendritic Cells via TLR4 Pathway
- (2014) T. Chen et al. JOURNAL OF IMMUNOLOGY
- MicroRNAs activate natural killer cells through Toll-like receptor signaling
- (2013) S. He et al. BLOOD
- Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study
- (2013) Alexa J Resler et al. BMC CANCER
- Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors
- (2013) Nicolas Isambert et al. BMC CANCER
- Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours
- (2013) M Millward et al. BRITISH JOURNAL OF CANCER
- Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue
- (2013) J H Kauppila et al. BRITISH JOURNAL OF CANCER
- A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer
- (2013) Daniela Fenoglio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells
- (2013) Ryan M. Stephenson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibition of TGF-β signaling in combination with TLR7 ligation re-programs a tumoricidal phenotype in tumor-associated macrophages
- (2013) Jiao Peng et al. CANCER LETTERS
- IL-24 sensitizes tumor cells to TLR3-mediated apoptosis
- (2013) R Weiss et al. CELL DEATH AND DIFFERENTIATION
- Myeloid Differentiation Factor 88 Promotes Growth and Metastasis of Human Hepatocellular Carcinoma
- (2013) B. Liang et al. CLINICAL CANCER RESEARCH
- Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model
- (2013) Aniruddha Roy et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck
- (2013) Jean-Pascal Machiels et al. INVESTIGATIONAL NEW DRUGS
- Decoding cell death signals in liver inflammation
- (2013) Catherine Brenner et al. JOURNAL OF HEPATOLOGY
- Local Administration of TLR Ligands Rescues the Function of Tumor-Infiltrating CD8 T Cells and Enhances the Antitumor Effect of Lentivector Immunization
- (2013) H. Xiao et al. JOURNAL OF IMMUNOLOGY
- Differential Effects of Phenethyl Isothiocyanate and D,L-Sulforaphane on TLR3 Signaling
- (2013) J. Zhu et al. JOURNAL OF IMMUNOLOGY
- High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
- (2013) Michele Sommariva et al. Journal of Translational Medicine
- The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial
- (2013) Paolo Gontero et al. JOURNAL OF UROLOGY
- Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial
- (2013) Olivier Richel et al. LANCET ONCOLOGY
- The application of Levulan®-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma
- (2013) Beata Osiecka et al. MEDICAL SCIENCE MONITOR
- Toll-Like Receptor 4 Engagement Drives Differentiation of Human and Murine Dendritic Cells from a Pro- into an Anti-Inflammatory Mode
- (2013) Romana Luger et al. PLoS One
- The Role of TLR2, TLR4 and CD14 Genetic Polymorphisms in Gastric Carcinogenesis: A Case-Control Study and Meta-Analysis
- (2013) Natalia Castaño-Rodríguez et al. PLoS One
- Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist
- (2013) L. G. Burdelya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast
- (2013) Naureen Ehsan et al. TUMOR BIOLOGY
- Positive association between Toll-like receptor 4 gene +896A/G polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis
- (2013) Tian-Hui Zou et al. TUMOR BIOLOGY
- FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4
- (2013) Kuppusamy Balamurugan et al. Nature Communications
- Aldara activates TLR7-independent immune defence
- (2013) Anne Walter et al. Nature Communications
- Links between Toll-like receptor 4 and breast cancer
- (2013) Abubakr Ahmed et al. OncoImmunology
- Signaling via MYD88 in the pancreatic tumor microenvironment
- (2013) Constantinos P. Zambirinis et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Laurie Menger et al. OncoImmunology
- Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies
- (2012) Brenda J. Weigel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Silencing of TLR4 Increases Tumor Progression and Lung Metastasis in a Murine Model of Breast Cancer
- (2012) Abubakr Ahmed et al. ANNALS OF SURGICAL ONCOLOGY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion
- (2012) Joonas H. Kauppila et al. APMIS
- Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis
- (2012) N. Eiró et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- A Randomized Trial of the Off-label Use of Imiquimod, 5%, Cream With vs Without Tazarotene, 0.1%, Gel for the Treatment of Lentigo Maligna, Followed by Conservative Staged Excisions
- (2012) Mark A. Hyde et al. ARCHIVES OF DERMATOLOGY
- Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers
- (2012) Zhen Huang et al. BIOMATERIALS
- Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
- (2012) S. J. Dovedi et al. BLOOD
- Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation
- (2012) T. V. Brennan et al. BLOOD
- The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility
- (2012) Xie Junjie et al. BMC CANCER
- Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide
- (2012) Ying-Ying Jing et al. BMC Medicine
- Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development
- (2012) George E. Theodoropoulos et al. BREAST
- Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
- (2012) Johanna Tuomela et al. BREAST CANCER RESEARCH AND TREATMENT
- Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study
- (2012) S. van der Geer et al. BRITISH JOURNAL OF DERMATOLOGY
- HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells
- (2012) Chunhong Wang et al. CANCER BIOLOGY & THERAPY
- STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
- (2012) Hazel Tye et al. CANCER CELL
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients
- (2012) Andrés Tittarelli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
- (2012) Katja Hattar et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Therapeutic Administration of a Synthetic CpG Oligodeoxynucleotide Triggers Formation of Anti-CpG Antibodies
- (2012) J. Karbach et al. CANCER RESEARCH
- Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells
- (2012) Ruan Min et al. CANCER SCIENCE
- Cytokine and chemokine modification by Toll-like receptor polymorphisms is associated with nasopharyngeal carcinoma
- (2012) Zhi-Hui Yang et al. CANCER SCIENCE
- Toll-like receptor 4 ligation confers chemoresistance to docetaxel on PC-3 human prostate cancer cells
- (2012) Yuntao Zhang et al. CELL BIOLOGY AND TOXICOLOGY
- dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8
- (2012) Y Estornes et al. CELL DEATH AND DIFFERENTIATION
- Extracts of Larix Leptolepis effectively augments the generation of tumor antigen-specific cytotoxic T lymphocytes via activation of dendritic cells in TLR-2 and TLR-4-dependent manner
- (2012) Shin-ichi Koizumi et al. CELLULAR IMMUNOLOGY
- Reevaluating the Concept of Treating Experimental Tumors with a Mixed Bacterial Vaccine: Coley’s Toxin
- (2012) C. Maletzki et al. Clinical & Developmental Immunology
- Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
- (2012) S. Adams et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
- (2012) P. Sabbatini et al. CLINICAL CANCER RESEARCH
- Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
- (2012) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- The TLR4 gene polymorphisms and susceptibility to cancer: A systematic review and meta-analysis
- (2012) Kui Zhang et al. EUROPEAN JOURNAL OF CANCER
- High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy
- (2012) Yi Luo et al. EUROPEAN JOURNAL OF CANCER
- Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients
- (2012) Simone M. Goldinger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
- (2012) Jorg Oddens et al. EUROPEAN UROLOGY
- High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
- (2012) Wei Yan et al. HEPATOLOGY
- Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure
- (2012) Pedro E. Marques et al. HEPATOLOGY
- Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice
- (2012) Heng Lin et al. HEPATOLOGY
- Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer
- (2012) Macarena Guirado et al. HUMAN IMMUNOLOGY
- Intratracheal and oral administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer
- (2012) Erina Koga-Yamakawa et al. INTERNATIONAL JOURNAL OF CANCER
- Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide
- (2012) Shingo Eikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer
- (2012) Xinqiang Hong et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- A 2-week Maintenance Regimen of Intravesical Instillation of Bacillus Calmette-Guerin is Safe, Adherent and Effective in Patients with Non-muscle-invasive Bladder Cancer: A Prospective, Multicenter Phase II Clinical Trial
- (2012) JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Toll-like Receptor 11 (TLR11) PreventsSalmonellaPenetration into the Murine Peyer Patches
- (2012) Zhongcheng Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Study of the Expression of Toll-Like Receptors in Different Histological Types of Colorectal Polyps and Their Relationship with Colorectal Cancer
- (2012) Noemí Eiró et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans
- (2012) Atsuo Ochi et al. JOURNAL OF CLINICAL INVESTIGATION
- TLR-4 expression and decrease in chronic inflammation: indicators of aggressive follicular thyroid carcinoma
- (2012) Jaana Hagström et al. JOURNAL OF CLINICAL PATHOLOGY
- MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells
- (2012) Atsuo Ochi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Coordination between TLR9 Signaling in Macrophages and CD3 Signaling in T Cells Induces Robust Expression of IL-30
- (2012) D. Dibra et al. JOURNAL OF IMMUNOLOGY
- A TLR5 Agonist Enhances CD8+ T Cell-Mediated Graft-versus-Tumor Effect without Exacerbating Graft-versus-Host Disease
- (2012) X. Ding et al. JOURNAL OF IMMUNOLOGY
- Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
- (2012) Y. Shirota et al. JOURNAL OF IMMUNOLOGY
- Combination of Cyclophosphamide, Rituximab, and Intratumoral CpG Oligodeoxynucleotide Successfully Eradicates Established B cell Lymphoma
- (2012) David J. Betting et al. JOURNAL OF IMMUNOTHERAPY
- Intratumoral Delivery of Low Doses of Anti-CD40 mAb Combined With Monophosphoryl Lipid A Induces Local and Systemic Antitumor Effects in Immunocompetent and T Cell-Deficient Mice
- (2012) Tyler J. Van De Voort et al. JOURNAL OF IMMUNOTHERAPY
- Association of Toll-Like Receptor 2 Polymorphisms with Papillary Thyroid Cancer and Clinicopathologic Features in a Korean Population
- (2012) Mi Kyeong Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: Clinical and histologic outcomes
- (2012) Carlos Serra-Guillén et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Toll-Like Receptor 3 Expressing Tumor Parenchyma and Infiltrating Natural Killer Cells in Hepatocellular Carcinoma Patients
- (2012) Valerie Chew et al. JNCI-Journal of the National Cancer Institute
- Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
- (2012) Erika Hamilton et al. Journal of Translational Medicine
- Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial
- (2012) Ashish M. Kamat et al. JOURNAL OF UROLOGY
- Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer
- (2012) Johannes Falke et al. JOURNAL OF UROLOGY
- The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes
- (2012) R Bomben et al. LEUKEMIA
- Involvement of toll-like receptor 9 polymorphism in cervical cancer development
- (2012) Andrzej Roszak et al. MOLECULAR BIOLOGY REPORTS
- Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis
- (2012) Zujun Sun et al. Molecular Cancer
- An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance
- (2012) Vincenzo Cerullo et al. MOLECULAR THERAPY
- The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock
- (2012) Ezra Aksoy et al. NATURE IMMUNOLOGY
- Inflammasomes in carcinogenesis and anticancer immune responses
- (2012) Laurence Zitvogel et al. NATURE IMMUNOLOGY
- Ultraviolet radiation damages self noncoding RNA and is detected by TLR3
- (2012) Jamie J Bernard et al. NATURE MEDICINE
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Mitochondria: master regulators of danger signalling
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Treatment of Cervical Intraepithelial Neoplasia With Topical Imiquimod
- (2012) Christoph Grimm et al. OBSTETRICS AND GYNECOLOGY
- Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia
- (2012) E Lainey et al. ONCOGENE
- Polymorphism of the TLR4 Gene Reduces the Risk of Hepatitis C Virus-Induced Hepatocellular Carcinoma
- (2012) José A. Agúndez et al. ONCOLOGY
- TLR4 Signaling Promotes Immune Escape of Human Colon Cancer Cells by Inducing Immunosuppressive Cytokines and Apoptosis Resistance
- (2012) Xiaoyan Tang et al. ONCOLOGY RESEARCH
- Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines
- (2012) Tomoyuki Tano et al. ORAL ONCOLOGY
- Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro
- (2012) Chih-Cheng Hsiao et al. PEDIATRIC BLOOD & CANCER
- S100A9 Interaction with TLR4 Promotes Tumor Growth
- (2012) Eva Källberg et al. PLoS One
- Mucin Depleted Foci, Colonic Preneoplastic Lesions Lacking Muc2, Show Up-Regulation of Tlr2 but Not Bacterial Infiltration
- (2012) Angelo Pietro Femia et al. PLoS One
- The Bacterial Preparation OK432 Induces IL-12p70 Secretion in Human Dendritic Cells in a TLR3 Dependent Manner
- (2012) Arnt-Ove Hovden et al. PLoS One
- An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy
- (2012) Huagang Zhang et al. PLoS One
- Gene Silencing of Toll-Like Receptor 2 Inhibits Proliferation of Human Liver Cancer Cells and Secretion of Inflammatory Cytokines
- (2012) Yuzheng Huang et al. PLoS One
- Peroxiredoxin 1 Stimulates Endothelial Cell Expression of VEGF via TLR4 Dependent Activation of HIF-1α
- (2012) Jonah R. Riddell et al. PLoS One
- TLR-4 Signalling Accelerates Colon Cancer Cell Adhesion via NF-κB Mediated Transcriptional Up-Regulation of Nox-1
- (2012) D. Peter O'Leary et al. PLoS One
- MicroRNA-574-5p Was Pivotal for TLR9 Signaling Enhanced Tumor Progression via Down-Regulating Checkpoint Suppressor 1 in Human Lung Cancer
- (2012) Qinchuan Li et al. PLoS One
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
- (2012) M. Fabbri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TLR13 Recognizes Bacterial 23S rRNA Devoid of Erythromycin Resistance-Forming Modification
- (2012) M. Oldenburg et al. SCIENCE
- Structural Basis of TLR5-Flagellin Recognition and Signaling
- (2012) S.-i. Yoon et al. SCIENCE
- The Structure of the TLR5-Flagellin Complex: A New Mode of Pathogen Detection, Conserved Receptor Dimerization for Signaling
- (2012) J. Lu et al. Science Signaling
- Simultaneous Targeting of Toll- and Nod-Like Receptors Induces Effective Tumor-Specific Immune Responses
- (2012) J. Garaude et al. Science Translational Medicine
- CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production
- (2012) Xiaoli Li et al. TUMOR BIOLOGY
- Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3–IRF3 signaling and type I interferons in dendritic cells
- (2012) Ce Wang et al. VACCINE
- How imiquimod licenses plasmacytoid dendritic cells to kill tumors
- (2012) Martin Holcmann et al. OncoImmunology
- Breaking the tolerance for tumor
- (2012) Theodore J. Standiford et al. OncoImmunology
- Activation of antigen-exposed iMC-DCs at the “right place” and “right time” promotes potent anti-tumor immunity
- (2012) David M. Spencer OncoImmunology
- Immune surveillance of pre-cancerous senescent hepatocytes limits hepatocellular carcinoma development
- (2012) Tetyana Yevsa et al. OncoImmunology
- Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation
- (2012) Apostolis Stathopoulos et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Targeting the right regulatory T-cell population for tumor immunotherapy
- (2012) Vivian L. Weiss et al. OncoImmunology
- Ipilimumab in a Phase II trial of melanoma patients with brain metastases
- (2012) Kim Margolin OncoImmunology
- "Flagellated" cancer cells propel anti-tumor immunity
- (2012) Johan Garaude et al. OncoImmunology
- A novel strategy for modulation of MDSC to enhance cancer immunotherapy
- (2012) Tomar Ghansah OncoImmunology
- Sound efficacy of prophylactic HPV vaccination
- (2012) Matti Lehtinen et al. OncoImmunology
- A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells
- (2012) Madhusoodhanan Rakhesh et al. OncoImmunology
- Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity
- (2012) Ravi A Madan et al. OncoImmunology
- Identification of a G-CSF-Granulocytic MDSC axis that promotes tumor progression
- (2012) Scott I. Abrams et al. OncoImmunology
- Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination
- (2012) Goodwin Jinesh G. et al. OncoImmunology
- Rage mediated DAMP signaling in intestinal tumorigenesis
- (2012) Jarom Heijmans et al. OncoImmunology
- CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection
- (2012) Rebecca Waitz et al. OncoImmunology
- Effect of CpG ODN on monocytic myeloid derived suppressor cells
- (2012) Hidekazu Shirota et al. OncoImmunology
- S100A9 and tumor growth
- (2012) Tomas Leanderson et al. OncoImmunology
- Systemic cancer immunotherapy with Toll-like receptor 7 agonists
- (2012) Christian Hotz et al. OncoImmunology
- The role of innate immune signals in antitumor immunity
- (2012) Masahisa Jinushi OncoImmunology
- Modulation of DNA repair genes induced by TLR9 agonists
- (2012) Michele Sommariva et al. OncoImmunology
- Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
- (2012) Minu K. Srivastava et al. OncoImmunology
- TLR4 signaling induces the release of microparticles by tumor cells that regulate inflammatory cytokine IL-6 of macrophages via microRNA let-7b
- (2012) Dapeng Li et al. OncoImmunology
- Plasmacytoid dendritic cells and their therapeutic activity in cancer
- (2012) Aldo Pinto et al. OncoImmunology
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth
- (2012) Taku Fujimura et al. OncoImmunology
- Chemoimmunomodulation of MDSCs as a novel strategy for cancer therapy
- (2012) Julie Djeu et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination
- (2012) Taylor H. Schreiber et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
- (2012) Erika Vacchelli et al. OncoImmunology
- Targeting PD-1/PD-L1 interactions for cancer immunotherapy
- (2012) Laurence Zitvogel et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting
- (2012) Koji Kono et al. OncoImmunology
- Toll-Like Receptor 7 Agonist Therapy with Imidazoquinoline Enhances Cancer Cell Death and Increases Lymphocytic Infiltration and Proinflammatory Cytokine Production in Established Tumors of a Renal Cell Carcinoma Mouse Model
- (2012) Eric C. Kauffman et al. Journal of Oncology
- An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma
- (2011) J. Stebbing et al. ANNALS OF ONCOLOGY
- In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
- (2011) Y. H. Kim et al. BLOOD
- Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration
- (2011) Sheng-Jun Liao et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice
- (2011) Jon Hansen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intrapleural Chemo- and Hyperthermotherapies for Malignant Pleural Effusion: A Randomized Prospective Study
- (2011) Wen-Jun Chen et al. CANCER INVESTIGATION
- Extracellular HSPA1A promotes the growth of hepatocarcinoma by augmenting tumor cell proliferation and apoptosis-resistance
- (2011) Feng-Hua Wu et al. CANCER LETTERS
- IFN Produced by TLR4-Activated Tumor Cells Is Involved in Improving the Antitumoral Immune Response
- (2011) N. G. Nunez et al. CANCER RESEARCH
- Immunotherapy with PI3K Inhibitor and Toll-Like Receptor Agonist Induces IFN- +IL-17+ Polyfunctional T Cells That Mediate Rejection of Murine Tumors
- (2011) N. A. Marshall et al. CANCER RESEARCH
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88
- (2011) Adetutu T. Egunsola et al. CELLULAR IMMUNOLOGY
- Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
- (2011) Alja Oblak et al. Clinical & Developmental Immunology
- VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
- (2011) H. Lu et al. CLINICAL CANCER RESEARCH
- The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma
- (2011) A Carvalho et al. GENES AND IMMUNITY
- A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen
- (2011) Kazuhiro Kakimi et al. INTERNATIONAL JOURNAL OF CANCER
- Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice
- (2011) Mohammed Naseemuddin et al. INTERNATIONAL JOURNAL OF CANCER
- The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C
- (2011) Hans-Dieter Nischalke et al. INTERNATIONAL JOURNAL OF CANCER
- Toll-like Receptor 5 Agonist Protects Mice From Dermatitis and Oral Mucositis Caused by Local Radiation: Implications for Head-and-Neck Cancer Radiotherapy
- (2011) Lyudmila G. Burdelya et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil
- (2011) Valerie Florin et al. INVESTIGATIONAL NEW DRUGS
- Randomized Trial: Immunogenicity and Safety of Coadministered Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine and Combined Hepatitis A and B Vaccine in Girls
- (2011) Court Pedersen et al. JOURNAL OF ADOLESCENT HEALTH
- TLR9 expression is associated with prognosis in patients with glioblastoma multiforme
- (2011) Lige Leng et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients
- (2011) Hisahito Endo et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Immunomodulation by Imiquimod in Patients with High-Risk Primary Melanoma
- (2011) Rupa Narayan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mycobacterial Strains That Stimulate the Immune System Most Efficiently as Candidates for the Treatment of Bladder Cancer
- (2011) Zehra Stara Yuksel et al. JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY
- Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses
- (2011) I. Jolanda M. de Vries et al. MOLECULAR IMMUNOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Toll-like receptor 3-mediated tumor invasion in head and neck cancer
- (2011) Hui-Ching Chuang et al. ORAL ONCOLOGY
- Association of Inherited Variation in Toll-Like Receptor Genes with Malignant Melanoma Susceptibility and Survival
- (2011) Andreas Gast et al. PLoS One
- Sequence variants of toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men
- (2011) Hae Jong Kim et al. WORLD JOURNAL OF UROLOGY
- Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells
- (2010) G. Schreibelt et al. BLOOD
- Circulating mitochondrial DAMPs cause inflammatory responses to injury
- (2010) Qin Zhang et al. NATURE
- The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells
- (2010) Karin Loser et al. NATURE MEDICINE
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- Clinical Development of the Anti–CTLA-4 Antibody Tremelimumab
- (2010) Antoni Ribas SEMINARS IN ONCOLOGY
- Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate–gene association study
- (2009) Vassiliki Mollaki et al. JOURNAL OF HUMAN GENETICS
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
- (2008) L. G. Burdelya et al. SCIENCE
- Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
- (2008) L. Liu et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started